Application of neural networks to pharmacodynamics
- PMID: 8229690
- DOI: 10.1002/jps.2600820910
Application of neural networks to pharmacodynamics
Abstract
Neural networks (NN) are computational systems implemented in software or hardware that attempt to simulate the neurological processing abilities of biological systems. A synopsis is presented of the operational characteristics, structures, and applications of NN. The NN technology has primarily been aimed at recognition science (e.g., handwriting, voice, signal, picture, image, pattern, etc.). It is pointed out that NN may also be particularly suitable to deal with pharmacokinetic (PK) and pharmacodynamic (PD) systems, especially in cases such as multivariate PK/PD population kinetics when the systems are so complex that modeling by a conventional structured model building technique is very troublesome. The main practical advantage of NN is the intrinsic ability to closely emulate virtually any multivariate system, including nonlinear systems, independently of structural/physiologic relevance. Thus, NN are most suitable to model the behavior of complex kinetic systems and unsuitable to model the structure. In a practical sense, this structure limitation may be inconsequential because NN in its multivariate formulation may consider any physiologic, clinical, or population variable that may influence the kinetic behavior. The application of NN in PD is demonstrated in terms of the ability of an NN to predict, by extrapolation, the central nervous system (CNS) activity of alfentanil. The drug was infused by a complex computer-controlled infusion scheme over 180 min with simultaneous recording of the CNS effect quantified by a fast Fourier transform power spectrum analysis. The NN was trained to recognize (emulate) the drug input-drug effect behavior of the PD system with the input-effect data for the 180 min as a training set.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Neural networks in pharmacodynamic modeling. Is current modeling practice of complex kinetic systems at a dead end?J Pharmacokinet Biopharm. 1992 Aug;20(4):397-412; discussion 413-8. doi: 10.1007/BF01062465. J Pharmacokinet Biopharm. 1992. PMID: 1479561
-
A system approach to pharmacodynamics. Input-effect control system analysis of central nervous system effect of alfentanil.J Pharm Sci. 1993 Mar;82(3):266-72. doi: 10.1002/jps.2600820310. J Pharm Sci. 1993. PMID: 8450420
-
Application of a variable direction hysteresis minimization approach in describing the central nervous system pharmacodynamic effects of alfentanil in rabbits.J Pharm Sci. 1994 Mar;83(3):351-6. doi: 10.1002/jps.2600830317. J Pharm Sci. 1994. PMID: 8207680
-
The use of artificial neural networks in biomedical technologies: an introduction.Biomed Instrum Technol. 1994 Jul-Aug;28(4):315-22. Biomed Instrum Technol. 1994. PMID: 7920848 Review.
-
NeuCube: a spiking neural network architecture for mapping, learning and understanding of spatio-temporal brain data.Neural Netw. 2014 Apr;52:62-76. doi: 10.1016/j.neunet.2014.01.006. Epub 2014 Jan 20. Neural Netw. 2014. PMID: 24508754 Review.
Cited by
-
Papain entrapment in alginate beads for stability improvement and site-specific delivery: physicochemical characterization and factorial optimization using neural network modeling.AAPS PharmSciTech. 2005 Sep 30;6(2):E209-22. doi: 10.1208/pt060231. AAPS PharmSciTech. 2005. PMID: 16353980 Free PMC article.
-
Neural network predicted peak and trough gentamicin concentrations.Pharm Res. 1995 Mar;12(3):406-12. doi: 10.1023/a:1016260720218. Pharm Res. 1995. PMID: 7617529
-
The novel application of artificial neural network on bioelectrical impedance analysis to assess the body composition in elderly.Nutr J. 2013 Feb 6;12:21. doi: 10.1186/1475-2891-12-21. Nutr J. 2013. PMID: 23388042 Free PMC article.
-
Neural network based on adaptive resonance theory as compared to experts in suggesting treatment for schizophrenic and unipolar depressed in-patients.J Med Syst. 1996 Dec;20(6):403-12. doi: 10.1007/BF02257284. J Med Syst. 1996. PMID: 9087885 Clinical Trial.
-
Artificial Intelligence and Machine Learning Approaches to Facilitate Therapeutic Drug Management and Model-Informed Precision Dosing.Ther Drug Monit. 2023 Apr 1;45(2):143-150. doi: 10.1097/FTD.0000000000001078. Epub 2023 Feb 3. Ther Drug Monit. 2023. PMID: 36750470 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources